BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15921760)

  • 1. A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modes.
    Yoshikawa Y; Kondo M; Sakurai H; Kojima Y
    J Inorg Biochem; 2005 Jul; 99(7):1497-503. PubMed ID: 15921760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies.
    Yoshikawa Y; Ueda E; Kawabe K; Miyake H; Takino T; Sakurai H; Kojima Y
    J Biol Inorg Chem; 2002 Jan; 7(1-2):68-73. PubMed ID: 11862542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacology of the insulinomimetic effect of zinc complexes.
    Sakurai H; Adachi Y
    Biometals; 2005 Aug; 18(4):319-23. PubMed ID: 16158223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
    Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
    J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus.
    Yoshikawa Y; Ueda E; Miyake H; Sakurai H; Kojima Y
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1190-3. PubMed ID: 11243860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes.
    Yoshikawa Y; Ueda E; Kojima Y; Sakurai H
    Life Sci; 2004 Jun; 75(6):741-51. PubMed ID: 15172182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new type of orally active anti-diabetic Zn(II)-dithiocarbamate complex.
    Yoshikawa Y; Adachi Y; Sakurai H
    Life Sci; 2007 Jan; 80(8):759-66. PubMed ID: 17137606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) mice.
    Saha TK; Yoshikawa Y; Sakurai H
    ChemMedChem; 2007 Feb; 2(2):218-25. PubMed ID: 17245806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.
    Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H
    J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinomimetic Zn complex (Zn(opt)2) enhances insulin signaling pathway in 3T3-L1 adipocytes.
    Basuki W; Hiromura M; Sakurai H
    J Inorg Biochem; 2007 Apr; 101(4):692-9. PubMed ID: 17316811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insulinomimetic zinc(II) complexes of alpha-amino acids and their derivatives with Zn(N2O2) coordination mode.
    Yoshikawa Y; Ueda E; Suzuki Y; Yanagihara N; Sakurai H; Kojima Y
    Chem Pharm Bull (Tokyo); 2001 May; 49(5):652-4. PubMed ID: 11383627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands.
    Katoh A; Matsumura Y; Yoshikawa Y; Yasui H; Sakurai H
    J Inorg Biochem; 2009 Apr; 103(4):567-74. PubMed ID: 19162327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic zinc(II)-N-acetyl-L-cysteine complex: evaluations of in vitro insulinomimetic and in vivo blood glucose-lowering activities.
    Adachi Y; Yoshikawa Y; Sakurai H
    Biofactors; 2007; 29(4):213-23. PubMed ID: 18057552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood glucose lowering and toxicological effects of zinc (II) complexes with maltol, threonine, and picolinic acid.
    Kojima Y; Yoshikawa Y; Ueda E; Kondo M; Takahashi S; Matsukura T; Sakurai H; Hiroi T; Imaoka S; Funae Y
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):91-104. PubMed ID: 15080500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid and peptide bioconjugates of copper(II) and zinc(II) complexes with a modified N,N-bis(2-picolyl)amine ligand.
    Kirin SI; Dübon P; Weyhermüller T; Bill E; Metzler-Nolte N
    Inorg Chem; 2005 Jul; 44(15):5405-15. PubMed ID: 16022539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulinomimetic Zn(II) complexes as evaluated by both glucose-uptake activity and inhibition of free fatty acids release in isolated rat adipocytes.
    Nishide M; Yoshikawa Y; Yoshikawa EU; Matsumoto K; Sakurai H; Kajiwara NM
    Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1181-3. PubMed ID: 18670123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution equilibrium characterization of insulin-mimetic Zn(II) complexes.
    Jakusch T; Gajda-Schrantz K; Adachi Y; Sakurai H; Kiss T; Horváth L
    J Inorg Biochem; 2006 Sep; 100(9):1521-6. PubMed ID: 16824606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
    Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
    J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Zinc(II)/poly(gamma-glutamic acid) complex as an oral therapeutic for the treatment of type-2 diabetic KKAy mice.
    Karmaker S; Saha TK; Yoshikawa Y; Sakurai H
    Macromol Biosci; 2009 Mar; 9(3):279-86. PubMed ID: 18989849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulinomimetic zinc(II) complexes with natural products: in vitro evaluation and blood glucose lowering effect in KK-Ay mice with type 2 diabetes mellitus.
    Kojima Y; Yoshikawa Y; Ueda E; Ueda R; Yamamoto S; Kumekawa K; Yanagihara N; Sakurai H
    Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):1006-8. PubMed ID: 12913247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.